1.
Schnell O
Impact of Molecular Markers on Personalised-Treatment Concepts in Gliomas
Glioblastoma
European Association of NeuroOncology Magazine 2014; 4 (3): 109-115
Possible
genetic pathways in glioblastomas.
Glioblastomas can be differentiated into primary
GBM (de novo occurrence) or secondary GBM, which
originate from either a low-grade diffuse astrocytoma
(WHO grade II) directly or via malignant transformation
from an anaplastic astrocytoma WHO grade III.
It has been demonstrated that both GBM pathways
show genetic alterations at different time points and/
or in a different frequency. Some of them are shown
in this figure which was modified from the literature
[46].
Keywords:
genetic pathway,
glioblastoma,
scheme